UCLA validation is a significant achievement by GSS. UCLA is independent, authoritative and world-leading in the field. In addition, it has its own network of hospitals which it can introduce the products and technology of GSS into. This should result in sales to the UCLA hospital network and facilitate other sales in the US and globally. UCLA's determination speaks highly of the management team of GSS and its technology. Big tick for management. I like the style of GSS's management; the quiet delivery of impressive results.
UCLA imprimatur for GSS technology
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
-0.015(2.17%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 68.5¢ | 67.5¢ | $8.27K | 12.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34322 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 7757 | 1 |
View Market Depth
| Last trade - 13.57pm 29/11/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
